Daniel Haverstock

1 ta ish

Bayer (United States)

1. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women

   Dan Henry, Robert Bettis, Ernie Riffer +5

   Maqola20022 iqtibos

   ABIABI:AkademIndex/2026.other.180795